Showing results (671-680 of 1,087) with videos related to
Sort By:
Pageof 109
JACC. Cardiovascular Interventions|November 29, 2020
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical TrialBernardo Cortese, Gaetano Di Palma, Marcos Garcia Guimaraes, et al.Circulation|July 22, 2024
Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary SyndromeMarco Valgimigli, Antonio Landi, Dominick J Angiolillo, et al.Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 30, 2021
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysisAnne H Tavenier, Roxana Mehran, Mauro Chiarito, et al.Journal of Clinical Medicine|April 13, 2024
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary SyndromeRoberto Licordari, Francesco Costa, Victoria Garcia-Ruiz, et al.JACC. Cardiovascular Interventions|March 10, 2018
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2Roberta Rossini, Giuseppe Tarantini, Giuseppe Musumeci, et al.Circulation. Cardiovascular Interventions|October 18, 2022
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding RiskShqipdona Lahu, Antonia Presch, Gjin Ndrepepa, et al.American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.Journal of the American Heart Association|April 21, 2020
Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC StudyFrancesco Franchi, Fabiana Rollini, Gabriel Faz, et al.European Heart Journal|April 22, 2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.Pageof 109